SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Ruder J, Wally MK, Oliverio M, Seymour RB, Hsu JR. J. Orthop. Trauma 2017; 31(6): e179-e185.

Affiliation

*Department of Orthopaedic Surgery, Carolinas HealthCare System, Charlotte, NC; and†Carolinas Trauma Network Research Center of Excellence, Carolinas HealthCare System, Charlotte, NC.

Copyright

(Copyright © 2017, Lippincott Williams and Wilkins)

DOI

10.1097/BOT.0000000000000834

PMID

28538457

Abstract

OBJECTIVES: To determine opioid-prescribing practices to the orthopaedic trauma (OT) population at one Level I trauma center.

DESIGN: A retrospective study of discharge prescriptions for adult patients with OT. Prescription details, injury burden, and patient demographics were abstracted for patients from initial injury through a 2-month follow-up. SETTING: Level I trauma center. PATIENTS/PARTICIPANTS: Adult patients with OT admitted over a 30-day period (n = 110). INTERVENTION: All discharge and follow-up opioid prescriptions were recorded. MAIN OUTCOME MEASUREMENTS: Morphine milligram equivalents (MMEs) per day, number of opioid prescriptions, type/dose of medication prescribed.

RESULTS: One hundred thirty-five discharge prescriptions were written for 110 patients with orthopaedic injuries during the review period. All patients received opioids at the time of discharge. The MMEs prescribed at the time of discharge was 114 mg (54-300 mg) for a mean of 7.21 days (2-36.7 days). Although patients with preinjury risk factors were prescribed discharge opioids for a similar duration (7.00 days vs. 7.30 days, P = 0.81) than those without risk factors, they were prescribed significantly more MMEs than those without (130 vs. 108, P < 0.05) and were more likely to receive extended-release and long-acting opioids than those without (42.11% vs. 21.98%).

CONCLUSIONS: Pain management after OT continues to be opioid-centric despite involving a population at risk. Further focus on prescriber and patient education, risk evaluation with mitigation, guideline development, and comprehensive pain management strategies are warranted in the OT population. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.


Language: en

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print